Houston, TX — Luis H. Camacho, MD, MPH, is being recognized by Continental Who's Who for a Lifetime Achievement Award in Oncology and Hematology.
World-renowned Dr. Luis H. Camacho is a fellowship-trained
and board-certified oncologist and hematologist and has garnered over two
decades of professional excellence in the medical field. He is a well-seasoned
clinician and translational researcher with substantial experience in the
hospital and healthcare industry. In his current capacity, he is proudly
providing state-of-the-art and comprehensive guidance and treatment to patients
affected by cancer and blood disorders in an individualized and caring environment.
He firmly believes that "Cancer is not a fight … It's a journey of
personal and spiritual growth." He demonstrates this belief in his Medical
Director role at The Center for Oncology and Blood Disorders (COBD), a private
organization located at 6560 Fannin Street, Suite 1224 in Houston, Texas. Dr.
Camacho's practice focuses on about 50% oncology and 50% hematology.
Among his academic achievements, Dr. Camacho received his medical degree in
1988 from the Universidad Militar "Nueva Granada" in Bogotá, DC,
Colombia, followed by completing an internship program at Hospital Militar
Central / Hospital "La Victoria" in the same year. He completed an
Internal Medicine Residency in 1993 at the Hospital Militar Central
Universidad Militar "Nueva Granada."
To further his medical career, Dr. Camacho served as a Clinical Research
Assistant in the Division of Hematology and Oncology at The George Washington
University Medical Center from 1993 to 1995 and completed a General Internal
Medicine Internship at The George Washington University Medical Center in 1996.
He remained at The George Washington University Medical Center and completed an
additional General Internal Medicine Residency in 1998. In that same year, he
earned a Master in Public Health from The George Washington University School
of Public Health and Health Sciences. He pursued his medical career with a
completed Fellowship in Medical Oncology and Hematology in 2001 at Joan and
Sanford I. Weill Medical College of Cornell University and Memorial Sloan-Kettering
Cancer Center in New York. While there, he gained knowledge in Drug Development
and Immunotherapy.
Board-certified in Internal Medicine and Medical Oncology by the American Board
of Internal Medicine, Dr. Camacho continues to remain abreast of his field's
latest advancements. He maintains active
memberships with the American College of Physicians, the American Society of
Clinical Oncology, the American Society Hematology, and the American
Association for Cancer Research. He also serves on the board of the Texas
Society of Clinical Oncology.
Highly dedicated to improving healthcare in oncology and hematology, Dr.
Camacho has served as a principal investigator or co-investigator for more than
70 clinical trials. He has co-authored over 100 National and International
scientific abstracts. Dr. Camacho has published the results of his basic and
clinical research experience in numerous journals like The New England Journal
of Medicine, The Journal of Clinical Oncology, Cancer, Annals of Tropical Medicine
and Parasitology, British Journal of Cancer, Annals of Oncology, and other peer
- reviewed medical journals. "Safety and Activity of Anti–PD-L1 Antibody
in Patients with Advanced Cancer" was published in The New England Journal
of Medicine and cited 6387 times. Throughout his career, he has collaborated
with companies like Merck & Co., Amgen, and Pfizer.
Dr. Camacho dedicates this honorable recognition to his mentor in hematology at
George Washington University – Dr. Craig Kessler, a coagulation expert; Dr.
Victor Gordeuk, an iron expert from George Washington University; and Dr.
Raymond Warrell from Sloan Kettering, whom he worked with on drug development.
To learn more, please visit http://www.cobd.us/ and
https://www.linkedin.com/in/luis-h-camacho-30489a5a/.
